Efficacy in the use of Recombinant TSH (Thyrogen) in the Ablative Treatment of Compressive Goiters with low uptake of I-131

Alasbimn Journal Year 4, N° 13, October 2001

Efficacy in the use of Recombinant TSH (Thyrogen®) in the Ablative Treatment of Compressive Goiters with low uptake of I-131.

Article Nº AJ13-2

Alvaro L. Barroso, Eduardo L. Padrão, Leonardo L. Rezende, Rodrigo S. Assis, Paulo H. D. Leite, Mauro L. Faria

Inal Ciência e Saúde Ltda.

Correspondencia:

Inal Ciência e Saúde Ltda.
Av. Barbacena nº 1033, Bairro Santo Agostinho
Belo Horizonte (MG) - Brasil
Cep: 30.190-131
Telephone: 00-55-31-3337-5926
Fax: 00-55-31-3284-2495

e-mail: inalmn@horizontes.net

url: http://www.virtuos.net/inal

	Resumen / Summary
	Introduction
	Material and Methods
	Results
	Discussion
	Conclusion
	Bibliography
	Versión Completa / Complete Versión

Cita/Reference:
Barroso, Alvaro L., et al. Efficacy in the use of Recombinant TSH (Thyrogen®) in the Ablative Treatment of Compressive Goiters with low uptake of I-131. Alasbimn Journal 4 (13): October 2001. Article Nº AJ13-2.
http://www.alasbimnjournal.cl/revistas/13/tsh.html

Sitio desarrollado por SISIB - Universidad de Chile